Endothelial cells contribute to a subset of cardiac fibroblasts by undergoing endothelial-to-mesenchymal transition, but whether cardiac fibroblasts can adopt an endothelial cell fate and directly contribute to neovascularization after cardiac injury is not known. Here, using genetic fate map techniques, we demonstrate that cardiac fibroblasts rapidly adopt an endothelial-cell-like phenotype after acute ischaemic cardiac injury. Fibroblast-derived endothelial cells exhibit anatomical and functional characteristics of native endothelial cells. We show that the transcription factor p53 regulates such a switch in cardiac fibroblast fate. Loss of p53 in cardiac fibroblasts severely decreases the formation of fibroblastderived endothelial cells, reduces post-infarct vascular density and worsens cardiac function. Conversely, stimulation of the p53 pathway in cardiac fibroblasts augments mesenchymal-to-endothelial transition, enhances vascularity and improves cardiac function. These observations demonstrate that mesenchymal-to-endothelial transition contributes to neovascularization of the injured heart and represents a potential therapeutic target for enhancing cardiac repair.
The mammalian heart after acute injury heals primarily by fibrosis. Cardiac fibroblasts proliferate at the site of injury 1 and fibroblast proliferation is accompanied by recruitment of endothelial cells. Endothelial cells contribute to neovascularization of the injury region 2 and promote repair 3 . A close interaction between fibroblasts and endothelial cells is thought to regulate wound healing 4 . A subset of endothelial cells, by undergoing endothelial-mesenchymal transition, generates fibroblasts in the injury region 5 and cardiac fibroblasts express pro-angiogenic molecules that in turn promote angiogenesis 6, 7 . However, cardiac fibroblasts are thought to be terminally differentiated cells 8, 9 and whether they have the ability to adopt an endothelial phenotype and directly contribute to neovascularization after cardiac injury is not known. Here we demonstrate that cardiac fibroblasts undergo mesenchymal-endothelial transition to generate de novo endothelial cells in the injured heart and show that mesenchymal-endothelial transition (or MEndoT) can be augmented to enhance cardiac repair.
Cardiac fibroblasts adopt endothelial-cell-like fates
We used a genetic fate map strategy to label cardiac fibroblasts by crossing transgenic mice harbouring a tamoxifen-inducible Cre recombinase driven by fibroblast-specific regulatory sequence of the a2 (type 1) collagen gene (Col1a2-CreERT) [10] [11] [12] with the lineage reporter strain (Rosa26R tdTomato ) 13 to create Col1a2-CreERT:R26R tdTomato progeny mice. In these mice, administration of tamoxifen results in activation of Cre recombinase, and cells expressing Col1a2 at the time of tamoxifen administration are irreversibly labelled by tdTomato fluorescence. We administered tamoxifen for 10 days to adult Col1a2-CreERT:R26R tdTomato mice. Five days after cessation of tamoxifen administration, we observed that approximately 55% of all non-myocyte cells exhibited tdTomato fluorescence and greater than 96% and 99% of tdTomato fluorescent cells expressed the cardiac fibroblast markers domain discoidin receptor 2 (DDR2) and vimentin (Extended Data Fig. 1a-c) . Immunofluorescent staining showed that 87 6 9% and 99 6 0.5% (mean 6 s.e.m.) of tdTomato-labelled cells expressed DDR2 and vimentin, respectively, supporting flow cytometry data (Extended Data Fig. 1d, e ). tdTomato cells did not express endothelial markers VECAD and CD31 (99.9 6 0.06% and 99.8 6 0.02% negative, respectively; mean 6 s.e.m.) (Extended Data Fig. 1f, g) , and did not express the cardiac progenitor marker c-Kit nor markers of smooth muscle, macrophages and lymphatics (Extended Data Fig. 1h-k) . Cardiac myocytes did not express Cre recombinase as previously shown 10 . Taken together these data strongly suggest that cells exhibiting tdTomato fluorescence in hearts of Col1a2-CreERT:R26R tdTomato mice are cardiac fibroblasts and do not express canonical markers of other cardiovascular cell types.
We subjected Col1a2-CreERT:R26R tdTomato mice to ischaemiareperfusion cardiac injury 5 days after cessation of tamoxifen injection. By day 3 post-injury, 35 6 3% (mean 6 s.e.m.) of labelled cardiac fibroblasts in the region of injury expressed the endothelial-specific marker VECAD, while in sham-injured animals only rare labelled cells expressed VECAD (,0.3%) ( Fig. 1a-c) . Approximately 24 6 4%, 44 6 4% and 35 6 3% (mean 6 s.e.m.) of labelled cardiac fibroblasts also expressed other endothelial markers such as endothelial nitric oxide synthase (eNOS) and the endothelial tight junctional proteins claudin 5 (ref. 14) and occludin 14 , respectively ( Fig. 1a-c) . Mesenchymal-endothelial transition was most pronounced in the injury border zone and significantly decreased in regions remote from the infarct (Fig. 1c ). The fraction of cardiac fibroblasts expressing VECAD increased between 1 and 3 days post-injury and remained similar at 3, 7 and 14 days (Fig. 1d ). The fraction of tdTomatopositive cells expressing VECAD in sham-injured animals at 3, 7 and 14 days was 0.3 6 0.1%, 1.4 6 1.4% and 0.6 6 0.4% (mean 6 s.e.m., P . 0.05, one way ANOVA), demonstrating no temporal difference in the fraction of tdTomato-labelled cells expressing VECAD after sham injury.
As fibroblasts lie in close apposition to endothelial cells and pericytes, we performed super-resolution microscopy to validate our observations with confocal microscopy. Stimulated emission deletion (STED) microscopy is a form of super-resolution microscopy that provides an average lateral resolution of 30-40 nm compared to confocal microscopy, which provides an average lateral resolution of 250 nm (ref. 15) . Using STED we observed that tdTomato cells after injury express VECAD and can be distinguished from closely apposed endothelial cells not expressing tdTomato label ( Fig. 1e ). STED microscopy also demonstrated that tdTomato cells did not express pericyte markers NG2 or CD146 (Extended Data Fig. 1l , m).
We next investigated whether fibroblast-derived endothelial cells incorporate into capillaries in the infarct border zone. We perfused Col1a2-CreERT:R26R tdTomato mice with a fluorescent lipophilic dye DiO that labels endothelial cell membranes and has been used to identify the vasculature of solid organs including the heart 16 . In both longitudinal ( Fig. 1f , g) and transverse sections of capillaries ( Fig. 1h ) in the injury border zone, we observed that endothelial cells bearing the fibroblast label lined the lumen of the blood vessel, but the contribution was minimal in sham-injured animals ( Fig. 1f ). Luminal DiO 1 tdTomato 1 cells expressed VECAD (Extended Data Fig. 2a ), thus confirming the endothelial phenotype. Luminal surface area occupied by fibroblast-derived endothelial cells peaked at 7 days post-injury and remained similar at 14 days ( Fig. 1i ). Endothelial cells are known to take up acetylated LDL (acLDL) 17 . We systemically injected Col1a2-CreERT: R26R tdTomato mice 3 days after cardiac injury with fluorescent-labelled acLDL and observed that 41 6 8% (mean 6 s.e.m.) of fibroblast-derived endothelial cells took up acLDL, demonstrating their functional similarity to native endothelial cells ( Fig. 1j) .
A subset of cardiac fibroblasts after cardiac injury become myofibroblasts and express a-smooth muscle actin (aSMA) 18, 19 . We stained for 
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aSMA and found that 3 days after injury, 11 6 3% (mean 6 s.e.m.) of labelled cardiac fibroblasts in the injured region expressed aSMA but very few labelled cells co-expressed aSMA and VECAD, suggesting that cardiac fibroblasts undergoing mesenchymal-endothelial transition are distinct from myofibroblasts (Extended Data Fig. 2b-f ). We next determined whether substantial recombination in endothelial cells (that is, leaky promoter elements) could potentially confound our findings. Stochastic induction of Cre can occur after cardiac injury 20 . We injected Col1a2-CreERT:R26R tdTomato mice with vehicle (corn oil) instead of tamoxifen and observed rare labelled cardiac fibroblasts (,0.07% at 3 and 7 days) after ischaemic injury, demonstrating that injury alone did not lead to significant Cre activation (Extended Data Fig. 3a-c) .
Endothelial cells are known to undergo endothelial-mesenchymal transition and adopt a fibroblast phenotype after cardiac injury 5 . We investigated whether endothelial cells undergoing endothelial-mesenchymal transition would exhibit tdTomato fluorescence and be mistakenly included in our analysis. We performed immunofluorescent staining for Col1 and observed that approximately 6 6 1% (mean 6 s.e.m.) of endothelial cells after injury expressed Col1 but none of these cells exhibited tdTomato fluorescence (Extended Data Fig. 3d ). Conversely, tdTomatolabelled cells in the injury region that expressed VECAD did not stain for Col1 (Extended Data Fig. 3e ). Next, we crossed Col1a2-CreERT: R26R tdTomato mice with Col1-GFP transgenic mice, which have GFP expression directly driven by the Col1a1 promoter. GFP expression thus serves as a useful real-time reporter of Col1 expression 21, 22 . Progeny mice (Col1a2-CreERT:R26R tdTomato :Col1-GFP) were administered tamoxifen and subjected to ischaemic myocardial injury. At 3 days postinjury, tdTomato-labelled cells that expressed VECAD did not exhibit GFP fluorescence (Extended Data Fig. 4a ). Approximately 3 6 1% (mean 6 s.e.m.) of VECAD-positive cells were GFP positive but with the exception of rare cells, VECAD 1 GFP 1 cells did not exhibit tdTomato fluorescence (Extended Data Fig. 4b ).
Immunofluorescent staining for Cre protein in Col1a2-CreERT: R26R tdTomato mice hearts after injury demonstrated that tdTomato 1 VECAD 1 cells did not express Cre (Extended Data Fig. 4c -i), consistent with the earlier observation that these cells do not express type 1 collagen. In the absence of tamoxifen, tdTomato cells expressing Col1a2 would be expected to have Cre in their cytoplasm. In hearts of Col1a2-CreERT:R26R tdTomato :Col1-GFP mice, tdTomato-labelled cells that expressed type 1 collagen (GFP positive) exhibited cytoplasmic but not nuclear Cre staining (Extended Data Fig. 4j -m). Taken together, these observations demonstrate the fidelity of the Cre driver and argue against a 'leaky' Cre as the basis for our findings.
Next we investigated whether Col1a2-expressing endothelial progenitors in the heart or bone marrow could have been labelled during administration of tamoxifen and subsequently generated tdTomato 1 endothelial cells. We analysed the heart and bone marrow but observed that less than 0.5% of tdTomato cells in the heart (Extended Data Fig. 5a , b) or bone marrow (Extended Data Fig. 5c -f) expressed endothelial progenitor markers (CD133, CD34 and Flk1) 23 . Bone-marrow-derived mesenchymal stem cells did not exhibit tdTomato fluorescence, with the exception of rare cells (Extended Data Fig. 5g ). Collectively, these observations suggest that substantial labelling of endothelial progenitors did not occur, making them an unlikely source of tdTomato 1 endothelial cells.
Finally, we subjected FSP1-Cre:R26R tdTomato mice to ischaemic cardiac injury to confirm mesenchymal-endothelial transition with another Cre driver. The FSP1-Cre driver has been used to track cardiac fibroblast after in vivo reprogramming 8, 9 . By day 3 post injury, 31 6 4% and 23 6 5% of tdTomato-labelled cells in the injury region expressed the endothelial markers isolectin and VECAD, respectively, compared to 2 6 1% and 4 6 1% in sham-injured animals (Extended Data Fig. 6a-c) , confirming mesenchymal-endothelial transition observations made using the Col1a2-CreERT driver.
p53 mediates MEndoT ex vivo
We next investigated the mechanisms regulating mesenchymal-endothelial transition and hypothesized that cellular stress after cardiac injury has a role in mesenchymal-endothelial transition. p53 is an important cellular stress-response gene 24 , modulates reprogramming 25 and regulates epithelial-mesenchymal transition 26 . We observed that 37% of tdTomatolabelled cardiac fibroblasts expressed p53 at 3 days post injury. In contrast, rare labelled cells expressed p53 in the sham-injured heart ( Fig. 2a, b ). p53 expression in labelled fibroblasts peaked at 7 days after cardiac injury ( Fig. 2c ). By day 7 after injury, approximately 91 6 7% (mean 6 s.e.m.) of tdTomato-labelled cells expressing p53 co-expressed VECAD (Fig. 2d) , demonstrating a strong association between p53 and VECAD expression in tdTomato-labelled cells.
To determine whether p53 has a regulatory role in mesenchymalendothelial transition, we first established an ex vivo model. Cells subjected to types of cellular stress ex vivo, such as serum deprivation, upregulate p53 levels 27, 28 . We subjected cardiac fibroblasts to serum starvation and observed increased p53 levels by western blotting (Extended Data Fig. 7a, b ). We next seeded labelled cardiac fibroblasts (99% purity by flow cytometry) on matrigel (a mixture of basement membrane proteins that facilitates capillary tube formation) and subjected them to serum starvation. In contrast to control fibroblasts ( Fig. 2e , g), serum-starved fibroblasts formed capillary-tube-like structures, expressed VECAD ( Fig. 2f ) and took up acLDL ( Fig. 2h ), consistent with adoption of an endothelialcell-like phenotype.
Using gain-and loss-of-function approaches, we determined whether p53 affects serum-starvation-induced mesenchymal-endothelial transition ( Fig. 2i-o ). Serum deprivation induced cardiac fibroblasts to form tubes on matrigel ( Fig. 2i, j ), but addition of pifithrin-a, an inhibitor of p53 (ref. 29 ), decreased tube formation by 67% ( Fig. 2k, n) . Pifithrin-a did not have an effect on serum-fed cardiac fibroblasts (Extended Data Fig. 7c, d ). Next, we generated mice specifically deficient in fibroblast p53 by crossing Col1a2-CreERT:R26R tdTomato mice with mice having both p53 alleles floxed 30 . Progeny mice (Col1a2-CreERT:R26R tdTomato : p53 fl/fl ) were injected with tamoxifen at 8 weeks to delete p53 and label Col1a2-expressing p53-deficient cells (tdTomato 1 ). Cardiac fibroblasts were subsequently harvested and subjected to serum starvation. The absence of p53 decreased capillary tube formation on matrigel by 95% ( Fig. 2l, n) . We subsequently investigated whether activation of p53 signalling enhanced serum-deprivation-induced mesenchymal-endothelial transition. Cardiac fibroblasts subjected to serum starvation were treated with the small molecule RITA (reactivation of p53 and induction of tumour apoptosis) that inhibits ubiquitin-mediated p53 degradation and enhances p53 signalling 31 . RITA enhanced tube formation by 50% ( Fig. 2m, n) . RITA also increased tube formation in serum-fed cardiac fibroblasts but to a lesser degree (Extended Data Fig. 7c, d ). After serum deprivation, quantitative real-time polymerase chain reaction (qPCR) demonstrated 4-20-fold increased expression of endothelial-specific genes but treatment with pifithrin-a or the genetic deletion of p53 in cardiac fibroblasts significantly blunted induction of endothelial gene expression ( Fig. 2o ). Conversely, treatment of serum-starved cardiac fibroblasts with RITA significantly increased expression of endothelial-specific genes by 3-7-fold ( Fig. 2o ). Interestingly, overexpressing p53 in wild-type cardiac fibroblasts grown under serum-fed conditions did not induce expression of VECAD or other endothelial-specific genes, suggesting that enhancing p53 signalling in the absence of serum starvation is not sufficient to induce mesenchymal-endothelial transition.
We next performed chromatin immunoprecipitation (ChIP) for p53 on serum-starved cardiac fibroblasts and observed that p53 directly binds to promoter regions of endothelial-specific genes and the endothelial transcription factors Hoxa9 (ref. 32 ) and Hoxd3 (ref. 33 ) that are known to have an important role in endothelial differentiation (Fig. 2p ). Gene expression of Hoxa9 and Hoxd3 was also increased in cardiac fibroblasts by 6.53 6 1.74 and 7.18 6 1.16-fold, respectively, after serum starvation (mean 6 s.e.m., P , 0.05 compared to cardiac fibroblasts in 10% serum). Although an indirect effect of p53 cannot be excluded, ARTICLE RESEARCH these observations suggest that p53 at least in this model initiates an endothelial gene expression program by directly inducing transcription of endothelial-specific genes.
Using this ex vivo model, we next asked whether mesenchymalendothelial transition was reversible. Transforming growth factor-b (TGF-b) enhances endothelial-mesenchymal transition 5 and TGF-b added to cardiac fibroblasts at the onset of serum starvation prevented tube formation (Extended Data Fig. 8a, b ) and induction of VECAD expression (0.98 6 0.03-fold change in VECAD with TGF-b, mean 6 s.e.m., P . 0.05, n 5 3). Moreover, when TGF-b was added to serumstarved cardiac fibroblasts after they had already formed tubes, it led to 99% regression of tube formation (Extended Data Fig. 8c, d, g) . A similar effect was observed with adding back serum (Extended Fig. 8e-g) . VECAD expression also decreased by 56.46 2.4% (mean6 s.e.m, P , 0.05, n 5 3). Addition of pifithrin-a to serum-starved cardiac fibroblasts that had already formed tubes demonstrated significant disruption of formed tubes compared to PBS-treated controls (Extended Fig. 8h -n). These observations suggest that p53 is required for maintaining the endothelial phenotype of the fibroblast-derived endothelial-like cell. Notably, the fraction of fibroblast-derived endothelial cells was maintained at 14 days after cardiac injury in vivo (Figs 1d and 2c ) despite declining p53 levels suggestive of other factors stabilizing the endothelial phenotype.
p53 mediates MEndoT in injured heart
To determine whether p53 mediates mesenchymal-endothelial transition in vivo, we subjected Col1a2-CreERT:R26R tdTomato :p53 fl/fl mice to ischaemic cardiac injury 5 days after cessation of tamoxifen. Mice with intact p53 exhibited 6 6 0.64-fold increase (mean 6 s.e.m.) in cardiac fibroblast p53 levels 3 days after cardiac injury, but in mice with fibroblastspecific p53 deletion (referred to as Col1a2-CreERT:R26R tdTomato :p53 CKO 
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(conditional knock out)) the mean p53 expression in border zone cardiac fibroblasts failed to increase significantly ( Fig. 3a-c) . The degree of mesenchymal-endothelial transition at 3 days post-injury in Col1a2-CreERT:R26R tdTomato :p53 CKO mice decreased by 57% ( Fig. 3d-f ) and was associated with a decrease in capillary density in the injury region ( Fig. 3g ). Increase in vessel density in the injured heart is a critical postischaemic repair mechanism. Diminished neovascularization can lead to rapid decline in cardiac function after cardiac injury and is associated with worsened scarring 34 . Echocardiography on hearts of mice 7 days after cardiac injury showed significant worsening of cardiac function in p53 CKO mice (Fig. 3h, i) . Masson's trichrome staining demonstrated a greater amount of collagen deposition in the hearts of Col1a2-CreERT: R26R tdTomato :p53 CKO mice (Fig. 3j, k) . The degree of inflammatory infiltrate measured by the number of CD68-expressing macrophages was also significantly higher in the Col1a2-CreERT:R26R tdTomato :p53 CKO mice (Extended Data Fig. 9a, b, d) . These observations demonstrate that p53 is necessary for mesenchymal-endothelial transition to occur after ischaemic cardiac injury and that disruption of mesenchymal-endothelial transition is associated with diminished post-injury vascularity and cardiac function. We next looked at mechanisms inducing p53 expression in cardiac fibroblasts. Carboxy-terminal phosphorylation of histone H2A family member X (cH2AX) is a DNA damage response pathway upstream of p53, is activated by hypoxic endothelial cells and shown to have a critical role in endothelial cell proliferation and hypoxic neovascularization 35 . We observed that 90% of tdTomato cells that upregulated p53 co-expressed cH2AX, suggesting that the cH2AX pathway is strongly associated with p53 expression in fibroblasts undergoing mesenchymal-endothelial transition (Extended Data Fig. 10a-c) .
p53 activation enhances MEndoT after cardiac injury
We investigated whether stimulation of p53 signalling after cardiac injury enhances mesenchymal-endothelial transition after acute ischaemic cardiac injury. Col1a2-CreERT:R26R tdTomato mice injected with RITA daily for 3 days after cardiac injury exhibited significantly increased p53 expression in labelled fibroblasts (13 6 0.8-fold in RITA-injected animals versus 6-fold increase in PBS-injected animals) ( Fig. 4a-c) . RITA significantly enhanced the degree of mesenchymal-endothelial transition ( Fig. 4d-f ) and enhanced mesenchymal-endothelial transition was associated with a 26% increase in endothelial cells in the injury border zone (Fig. 4g ). Increased neovascularization can lead to decreased collagen deposition and rapid improvement in post-injury cardiac function 3 . The area of collagen deposition 7 days after cardiac injury decreased by 57% in RITA-injected animals (Fig. 4h, i) . Echocardiography demonstrated significantly improved cardiac function in RITA-injected mice compared to PBS-injected control mice (Fig. 4j, k) .
Consistent with greater vascularity and better cardiac function, the inflammatory infiltrate was substantially reduced in RITA-injected animals (Extended Fig. 9a, c, d) . As RITA increases p53 levels, we also looked at deleterious effects of increased p53 levels, such as apoptosis. We subjected Col1a2-CreERT:R26R tdTomato mice to cardiac injury and consistent with published reports, did not observe increased p53 expression in myocytes after injury (Extended Data Fig. 9e, f) 36 . In RITA-treated mice 3 days after injury there was not a significant increase in p53expressing TUNEL-stained nuclei compared to PBS-injected controls (Extended Data Fig. 9g ).
To demonstrate that increased mesenchymal-endothelial transition after administration of RITA was p53-dependent in cardiac fibroblasts, we injected RITA into Col1a2-CreERT:R26R tdTomato :p53 CKO mice and 
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observed that RITA failed to significantly enhance mesenchymalendothelial transition. The degree of mesenchymal-endothelial transition was not statistically different from that observed in PBS-treated Col1a2-CreERT:R26R tdTomato :p53 CKO mice (Extended Data Fig. 9h, i) . These observations suggest that RITA predominantly enhances mesenchymalendothelial transition by activating p53 in cardiac fibroblasts.
Discussion
Our report suggests that cardiac fibroblasts possess a degree of native cellular plasticity that enables them to adopt endothelial-cell-like fates after cardiac injury. Recruitment and proliferation of endothelial cells in the ischaemic heart is a critical cardiac repair response. Our data point to the fibroblast as a novel and robust source of endothelial cell generation in the injured heart. Mesenchymal-endothelial transition (or MEndoT), a hitherto unreported biological phenomenon, appears to have an important physiological role in cardiac repair, as disruption of mesenchymal-endothelial transition worsened post-infarct vascularity and cardiac function. Teleologically, mesenchymal-endothelial transition provides the heart with an efficient strategy to increase neovascularization rapidly in the injured region. The use of a small molecule to augment mesenchymal-endothelial transition and increase neovascularization after injury suggests that mesenchymal-endothelial transition may represent a therapeutic target for enhancing vascularity and repair of ischaemic tissues.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Animal care and use. All animal studies were approved by the Institutional Animal Care and Use Committee at the University of North Carolina, Chapel Hill and the University of California, Los Angeles. Generation of transgenic and conditional knockout mice. Collagen1a2-CreERT: R26R tdTomato mouse lines were obtained by crossing collagen1a2-CreERT mice with lineage reporter R26R tdTomato mice. To obtain collagen1a2-CreERT:R26R tdTomato : p53 CKO mice, collagen1a2-CreERT:R26R tdTomato mice were crossed to p53 fl/fl mice and backcrossed to generate collagen1a2-CreERT:R26R tdTomato :p53 fl/fl mice. Col1a2-CreERT:R26R tdTomato mice were crossed with Col1-GFP mice to create progeny Col1a2-CreERT:R26R tdTomato :Col1-GFP mice. FSP1-Cre mice were crossed with the R26R tdTomato mice to create FSP1-Cre:R26R tdTomato mice. Tamoxifen (1 mg) (Sigma) was injected intraperitoneally for 10 days to induce Cre-mediated recombination in Col1a2-CreERT mice. Five days following cessation of tamoxifen animals were subjected to ischaemic cardiac injury. All mice were on a C57BL/6 background. Murine cardiac injury model. Mice (both male and female), 8-10 weeks old, were randomly allocated to sham or ischaemia-reperfusion cardiac injury. Investigators performing surgeries and cardiac function studies were blinded to mouse genotype or treatment. Mice were initially anaesthetized with 3% isoflurane, maintained at 2% isoflurane, and intubated using a Harvard Rodent Volume-Cycled ventilator. Myocardial injury was induced by 30 min ligation of the left anterior descending (LAD) coronary artery followed by reperfusion. Sham injury was performed in the same manner, with a ligature passed under the LAD, but the LAD was not ligated. Group size was estimated based on previously observed mortality rates following surgery. No animals were excluded from analysis unless they died during the surgical procedure. At 1, 2, 3, 7 or 14 days after injury, the mice were anaesthetized with pentobarbital (45 mg kg 21 ) and the left ventricle was perfused with 5 ml PBS followed by 2 ml 4% PFA. For RITA-treated mice, beginning 24 h after injury RITA (Millipore) was administered intraperitoneally at 0.3 mg kg 21 once daily for 3 days or until harvest. For acLDL staining, 1 mg fluorescent labelled acLDL (Invitrogen) per gram body weight was injected via a catheter inserted in the jugular vein and hearts harvested as described 4 h later. For DiO staining, DiO was prepared as described 16 and 2 ml of 120 mg ml 21 DiO perfused before PFA perfusion 16 . After perfusion, the heart was further fixed for 1 h in 4% PFA at 4 uC and after 1 h the PFA was replaced with fresh 4% PFA and incubated at 4 uC for another 3 h. At the end of 4 h, the hearts were sucrose embedded overnight in a 30% sucrose solution (MP Biochemicals) and then frozen in OCT (Tissue-Tek). 7 mm sections were prepared in a longitudinal or transverse orientation. Echocardiography. Echocardiography was performed in conscious mice. The hair over the anterior chest was removed by a depilation cream and warmed Aquasonic gel applied over the thorax. Mice were held firmly by hand for the duration of the procedure (approximately 5-10 min) and conditioned daily for the procedure starting 3 days before the procedure. The probe was positioned over the chest in a parasternal position. Parasternal long axis B-mode and M-mode images are recorded. Measurements and analysis were then performed as described 10 . The echocardiographer was blinded to the genotype and treatment of the animal being examined. Immunohistochemistry and histology, confocal imaging and quantitation, super-resolution microscopy. Immunofluorescent staining on frozen sections (7 mm) was performed using primary antibodies to VECAD (catalogue number ab33168, Abcam), eNOS (ab66127, Abcam), claudin 5 (ab53765, Abcam), occludin (ab31721, Abcam), cH2AX (ab2893, Abcam), p53 (ab31333 and ab26, Abcam), Col1 (ab6308, Abcam), podoplanin (ab11936, Abcam), a-SMA (ab5694, Abcam), CD68 (ab125212, Abcam), CD146 (ab75769, Abcam), Cre (BIOT-106L & PRB-106P, Covance), troponin (SC-8121, Santa Cruz), NG2 (AB5320, EMD Millipore) and associated APC or fluorescein conjugated secondary antibodies (Abcam, Millipore, Invitrogen) as per manufacturer instructions. Labelled sections were imaged using a Leica SP2 AOBS Upright Laser Scanning Confocal Microscope (Leica Microsystems). Five independent images for each area (that is, injury border zone, remote from injury, sham) were obtained and used for quantitative analysis. Co-localization analysis of confocal images was performed using Image J software (NIH). Mesenchymalendothelial transition percentages were derived by counting the number of dually labelled cells and dividing by the number of tdTomato-positive cells. Quantification of vascular area derived from fibroblasts was performed using the JACoP Image J plugin 37 . p53 expression levels in tdTomato-positive cells were determined using the JACoP Image J plugin and expressed as a Manders coefficient normalized to p53 levels in sham injury 38 . In each case, five independent images from each area were analysed from sections prepared from each mouse. For super-resolution microscopy, a custom-made Stimulation Emission Depletion Super-resolution microscope was used. This microscope has a confocal channel for tdTomato and an ATTO647 flurophore super-resolution channel that was used for VECAD, NG2 or CD146 visualization. Masson's trichrome staining was performed on heart sections as described 10 .
Fibroblast isolation and culture. Cardiac fibroblasts were isolated from the explanted hearts of euthanized uninjured mice. The hearts were explanted and washed three times with 13 HBSS (Gibco). The heart was minced into approximately 1-mm 2 sized pieces and digested using 10 ml of a 0.1% trypsin solution (Gibco) with 50 U ml 21 collagenase II (Worthington) 39 . Five sequential digestions were performed at 37 uC, the cells collected and passed through a 40 mM strainer and plated in IMDM, 13 penicillin/streptomycin, 10% FBS for 1 h at 37 uC. After 1 h the medium was changed to F12K 13 penicillin/streptomycin, 10% FBS (Gibco), 10 ng ml 21 leukaemia inhibitory factor (LIF) (Millipore) and 10 ng ml 21 basic fibroblast growth factor (bFGF) (Millipore). Cells were maintained under these conditions until they became confluent in 7-10 days. Matrigel tube formation and LDL uptake assay. 6 3 10 4 fibroblasts per cm 2 were cultured overnight at 37 uC, 5% CO 2 on Growth Factor Reduced Matrigel Basement Membrane Matrix (BD Biosciences) coated wells of Nunc Lab-Tek II CC2 chamber slides (Thermo). Serum starved or unstarved cells were cultured in IMDM, 13 penicillin/streptomycin or IMDM, 13 penicillin/streptomycin, 10% fetal bovine serum (Gibco), respectively. Pifithrin-a 100 mM (P4359, Sigma) or RITA 0.1 mM (506149, EMD Chemicals) were added to the cells cultured with the above culture medium. Acetylated LDL (Invitrogen) uptake was performed as described 40 . Flow cytometry. Flow cytometric analysis for cell surface markers were done using antibodies CD31-APC (17-0311, eBioScience), CD34-FITC (11-0341, eBioscience), CD133-FITC (11-1331, eBioscience), Flk1-APC (17-5821, eBioscience), VECAD-APC (17-1441, eBioscience), CD45-APC (103111, Biolegend), c-Kit APC (561074,BD Bioscience), DDR2 (SC-7555, Santa Cruz) and vimentin (Ab1620, Millipore). For vimentin and DDR2, a secondary APC conjugated anti-goat antibody was used (SC3860, Santa Cruz). Cultured cardiac fibroblasts were dissociated using accutase (Innovative Cell Technologies) and immunostained in FACS buffer (0.1% BSA PBS) at 1 3 10 6 per ml for 20-30 min at 4 uC, followed by washing twice with FACS buffer and subsequently analysed in Beckman-Coulter (Dako) CyAn ADP. Data obtained was analysed and represented using Flowjo software. Quantitative real-time PCR. RNA was isolated from cardiac fibroblasts cultured in the presence or absence of serum (IMDM, 13 penicillin/streptomycin, with without 10% FBS), or in medium without serum and containing either 100 mM pifithrin-a or 0.1 mM RITA, grown for 48 h at 37 uC, 5% CO 2 . RNA isolation and reverse transcription was performed using the SV Total RNA Isolation Kit and the Reverse Transcription System (Promega). qPCR was performed using the SensiMix SYBR and Fluorescein Kit (Quantace) on an iQ5 thermal cycler (BioRad). Western blot. Protein was harvested from cardiac fibroblasts cultured in the presence or absence of serum (IMDM, 13 penicillin/streptomycin, with or without 10% FBS) for 24, 48 and 72 h at 37 uC, 5% CO 2 .
Concentration normalized protein was prepared with SDS loading buffer and run on a 123 Mini-Protean TGX gel (BioRad) at 300V for 25 min. The protein was transferred from the gel to a nitrocellulose membrane using the Trans-Blot Turbo System (BioRad). After blocking with TBST 13% cold fish gelatin, the membrane was probed using primary antibodies to p53 (ab31333, Abcam) and a-tubulin (T6199, Sigma), washed with TBST, and labelled using fluorescently conjugated secondary antibodies (LI-COR Biosciences). After washing with TBST, the membrane was visualized on an Odyssey scanner (LI-COR Biosciences). Densitometry analysis was performed using the Gel Analyzer unit of ImageJ software (NIH). Chromatin immunoprecipitation (ChIP). Cardiac fibroblasts (30 3 10 6 ) were fixed in 1% formaldehyde, lysed in lysis buffer (50 mM Tris-HCl pH 8, 10 mM EDTA, 1% SDS, protease inhibitor cocktail Set I CALBIOCHEM) and sonicated using a EpiShear Multi-Sample Sonicator (Active Motif), leading to fragments between 300 and 1,000 bp. ChIP was performed using a commercially available ChIP-IT High Sensitivity Kit (Active Motif) according to manufacturer's instructions. DNA-bound protein was immunoprecipitated using an anti-p53 antibody (ab31333, Abcam) and anti IgG (SC-2025, Santa Cruz) as a negative control. The DNA recovered was analysed by quantitative real time-PCR using different primers sets that amplified the promoter region of Hoxa9, Hoxd3, CLDN5, Nos3 and negative control genes: Hoxa9 (1) 59-TAAACTGCTCAGGCCATGCT-39 sense, 59-CAGCCTGGACCCACTGAAAG-39 antisense; Hoxd3 (1) 59-TGCCTCAGT GTATTTCTCCCC-39 sense, 59-ATGGATAACAGTGCCCGGTG-39 antisense; claudin 5 59-CTCCGGAAGCCAACTTGGAG-39 sense, 59-GGACCCAGTGTG TCTAACCC-39 antisense; eNOS 59-GGGACAGCCAGAAAATGGGA-39 sense, 59-ACTGCTGTCGGTCTCTTTGT-39 antisense.
Primers for p53 binding were designed using the SABiosciences' proprietary database (DECODE, DECipherment Of DNA Elements), available from http:// www.sabiosciences.com/chipqpcr.php.
PCR was performed with equal amounts of specific antibody immunoprecipitated sample, control (IgG) and input. Values were normalized to input measurements and enrichment was calculated using the comparative D-DCt (DDCt) ARTICLE RESEARCH method. Data shown correspond to one representative assay (that is, three PCRs) from a total of three independent assays each run with different sets of treated cells. Statistical analysis. Statistical analysis was performed using GraphPad software (Prizm) using Student's t-test (two-tailed), one-way or two-way ANOVA with Bonferroni post-test analysis as appropriate. Welch's correction was used if variances between groups were significantly different. A P value of ,0.05 was considered statistically significant. Graphs present the mean value 6 standard error of the mean (s.e.m.). 195-198 (1997) . 40. Nagelkerke, J. F., Barto, K. P. & van Berkel, T. J. In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells. J. Biol. Chem. 258, 12221-12227 (1983).
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Extended Data Figure 3 | tdTomato expression in hearts of vehicle-injected
Col1a2-CreERT:R26R tdTomato mice and immunostaining for Col1 and VECAD in tamoxifen-injected Col1a2-CreERT:R26R tdTomato mice after cardiac injury. a-c, Oil-injected Col1a2-CreERT:R26R tdTomato mice underwent ischaemia reperfusion injury and 3 days after injury, hearts were harvested and sectioned. Area of injury (white lines) was stained with Alexa488-labelled wheat germ agglutinin (a) (WGA, stains cell membranes), rare tdTomato-expressing cells in same field (b) (arrowhead) and merged image (c) showing the presence of rare labelled cells in the injury region (arrowhead) (28 labelled cells out of 38,000 cells counted (0.07%), n 5 3 mice). Scale bar: 100 mm. d, e, Col1a2-Cre:R26R tdTomato mice (injected with tamoxifen as described in text) were subjected to ischaemic cardiac injury and hearts harvested 3 days post injury and stained for Col1 and VECAD. d, Region of injury demonstrating a VECAD-expressing cell (blue, arrow) staining positive for Col1 (green) but negative for the tdTomato label (merged arrow). Arrowheads in merged panel show tdTomato-labelled cells expressing VECAD but not Col1. Scale bar, 10 mm. e, tdTomato-labelled cells expressing VECAD (arrowheads) that do not stain for Col1 (green) with merged image showing tdTomato 1 VECAD 1 cells not staining with the Col1 antibody. Out of 225 cells counted (n 5 3 mice), we did not observe a single tdTomato 1 VECAD 1 cell to stain for Col1. Conversely, not a single VECAD 1 Col1 1 cell exhibited tdTomato fluorescence. Scale bar, 10 mm.
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